183 related articles for article (PubMed ID: 23022226)
1. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload.
Agius L
Biochem Pharmacol; 2013 Feb; 85(3):306-12. PubMed ID: 23022226
[TBL] [Abstract][Full Text] [Related]
2. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
3. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis.
Arden C; Petrie JL; Tudhope SJ; Al-Oanzi Z; Claydon AJ; Beynon RJ; Towle HC; Agius L
Diabetes; 2011 Dec; 60(12):3110-20. PubMed ID: 22013014
[TBL] [Abstract][Full Text] [Related]
4. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
5. Dietary carbohydrate and control of hepatic gene expression: mechanistic links from ATP and phosphate ester homeostasis to the carbohydrate-response element-binding protein.
Agius L
Proc Nutr Soc; 2016 Feb; 75(1):10-18. PubMed ID: 26264689
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
7. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
9. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice.
Bricambert J; Miranda J; Benhamed F; Girard J; Postic C; Dentin R
J Clin Invest; 2010 Dec; 120(12):4316-31. PubMed ID: 21084751
[TBL] [Abstract][Full Text] [Related]
10. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
[TBL] [Abstract][Full Text] [Related]
11. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish.
Gong Y; Lu Q; Xi L; Liu Y; Yang B; Su J; Liu H; Jin J; Zhang Z; Yang Y; Zhu X; Xie S; Han D
J Nutr Biochem; 2023 Dec; 122():109452. PubMed ID: 37748621
[TBL] [Abstract][Full Text] [Related]
12. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
Robichon C; Girard J; Postic C
Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
[TBL] [Abstract][Full Text] [Related]
13. Txnip contributes to impaired glucose tolerance by upregulating the expression of genes involved in hepatic gluconeogenesis in mice.
Jo SH; Kim MY; Park JM; Kim TH; Ahn YH
Diabetologia; 2013 Dec; 56(12):2723-32. PubMed ID: 24037087
[TBL] [Abstract][Full Text] [Related]
14. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
16. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
17. Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes.
Arden C; Tudhope SJ; Petrie JL; Al-Oanzi ZH; Cullen KS; Lange AJ; Towle HC; Agius L
Biochem J; 2012 Apr; 443(1):111-23. PubMed ID: 22214556
[TBL] [Abstract][Full Text] [Related]
18. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
19. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
[TBL] [Abstract][Full Text] [Related]
20. The regulation and role of carbohydrate response element-binding protein in metabolic homeostasis and disease.
Jois T; Sleeman MW
J Neuroendocrinol; 2017 Oct; 29(10):. PubMed ID: 28370553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
